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New Mutations at the Imprinted Gnas Cluster Show Gene Dosage
Effects of Gs in Postnatal Growth and Implicate XLs in Bone and
Fat Metabolism but Not in Suckling
Sally A. Eaton,a* Christine M. Williamson,a Simon T. Ball,a Colin V. Beechey,a Lee Moir,a Jessica Edwards,a Lydia Teboul,b
Mark Maconochie,c and Jo Petersa
Mammalian Genetics Unit, MRC Harwell, Harwell Science and Innovation Campus, Oxfordshire, United Kingdoma; Mary Lyon Centre MRC Harwell, Harwell Science and
Innovation Campus, Oxfordshire, United Kingdomb; and School of Life Sciences, University of Sussex, Brighton, East Sussex, United Kingdomc
The imprintedGnas cluster is involved in obesity, energy metabolism, feeding behavior, and viability. Relative contribution of
paternally expressed proteins XLs, XLN1, and ALEX or a double dose of maternally expressed Gs to phenotype has not been
established. In this study, we have generated two newmutants (Ex1A-T-CON and Ex1A-T) at theGnas cluster. Paternal inheri-
tance of Ex1A-T-CON leads to loss of imprinting of Gs, resulting in preweaning growth retardation followed by catch-up
growth. Paternal inheritance of Ex1A-T leads to loss of imprinting of Gs and loss of expression of XLs and XLN1. These mice
have severe preweaning growth retardation and incomplete catch-up growth. They are fully viable probably because suckling is
unimpaired, unlike mutants in which the expression of all the known paternally expressedGnasxl proteins (XLs, XLN1 and
ALEX) is compromised. We suggest that loss of ALEX is most likely responsible for the suckling defects previously observed. In
adults, paternal inheritance of Ex1A-T results in an increased metabolic rate and reductions in fat mass, leptin, and bone mineral
density attributable to loss of XLs. This is, to our knowledge, the first report describing a role for XLs in bone metabolism.We
propose that XLs is involved in the regulation of bone and adipocyte metabolism.
If the major modern day problems of obesity and diabetes are tobe solved, a full understanding of genetic involvement inmetab-
olism and food intake is needed. The imprintedGnas/GNAS clus-
ter located on chromosome 2 in mice and chromosome 20 in
humans has an important role in metabolism (13, 60). Genomic
imprinting results in the expression of a subset of genes according
to parental origin. TheGnas cluster contains a number of different
transcripts that are maternally, paternally, and/or biallelically ex-
pressed (47) (Fig. 1). The cluster contains three promoter regions
giving rise to protein coding transcripts, Nesp, Gnasxl, and Gnas
encoding the proteins Nesp55, XLs, and Gs, respectively (46).
Nesp, Gnasxl, and Gnas all possess a unique first exon(s) which is
spliced onto exon 2 of Gnas, and thus from this point on, all
transcripts are identical in their sequence. Full-length transcripts
extend through to exon 12 of Gnas, but there are also shortened
neural transcripts of Gnas/Gnasxl that terminate prematurely be-
fore exon 4 called GsN1/XLN1 (16, 44). Furthermore, a protein
of unknown function, ALEX, is generated from an alternative
reading frame of the Gnasxl transcript. Although the Gnasxl tran-
script encodes both proteins XLs and ALEX, ALEX is generated
only from the first Gnasxl exon, the remainder of the transcript is
its 3= untranslated region (UTR) (34).
Of these transcripts, Nesp is exclusively maternally expressed
(33, 47), Gnas is predominantly biallelically expressed in most
tissues but is maternally expressed in tissues such as proximal
renal tubules, paraventricular nucleus of the hypothalamus, and
neonatal brown adipose tissue (BAT) (14, 61, 69). Gnas has also
been shown to be maternally expressed in the pituitary in both
humans (26) and neonatal mice (J. Skinner, unpublished data).
Gnasxl is exclusively paternally expressed (1, 33, 39, 47). Both Gs
and XLs function as the alpha subunit of the heterotrimeric Gs
signaling protein. Gs has been shown by both in vitro and in vivo
studies, and XLs by in vitro studies, to stimulate adenylyl cyclase
and regulate receptor-stimulated cyclic AMP (cAMP) production
(5, 25, 30, 35). There have, however, been reports that XLs may
act antagonistically to Gs, as it represses adenylyl cyclase and
cAMP signaling in vivo (48, 65). While Gs is widely expressed,
XLs displays a more discrete expression pattern; it is expressed
primarily in neuroendocrine tissues such as the pituitary and
orexigenic neurons in the hypothalamuses of neonatal and adult
rodents (28, 31, 43, 44, 48).
A number of mutations leading to loss of function within the
Gnas cluster in mice have been described. A summary of some of
these mutations is given in Table 1. From this table, it is clear that
defects in maternal Gnas expression and paternal Gnasxl expres-
sion result in a series of opposite metabolic phenotypes that occur
from the neonate to the adult. Mice that have a defect in maternal
Gnas expression show increased adiposity 2 days after birth. As
adults, they are obese and have a lower metabolic rate and lower
sympathetic activity (12, 68). In contrast, neonates with a defect in
paternalGnasxl expression have decreased adiposity. These adults
have less fatmass, a highermetabolic rate, and higher sympathetic
activity (48, 65, 68). Furthermore, Gnasxl is also important in
feeding behavior; loss of all Gnasxl transcripts is associated with
poor suckling (48, 69). However, mice carrying the GnasOedsml-pat
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(Sml) allele suckle normally, although they have the raised meta-
bolic rate characteristic of Gnasxl loss. These mice carry a point
mutation in exon 6which results in nonfunctional XLs, but neu-
ral XLN1 and ALEX, which are not translated into protein at exon
6, are presumed to be unaffected, suggesting that the protein en-
coded by the full-length transcript controls the metabolic pheno-
type whereas suckling is controlled by the shortened proteins neu-
ral XLN1 and/or ALEX (32). The antagonistic biochemical and
phenotypic effects ofGnas andGnasxl and also the effect ofGnasxl
on feeding behavior accord with the “kinship” or “parental con-
flict” theory of the evolution of imprinting, which predicts that
paternal genes in offspring exert a high demand for maternal
FIG 1 Schematic diagram of the mouse Gnas cluster. Maternal (Mat) and paternal (Pat) transcripts are shown above and below the line, respectively.
Protein-coding first exons are shown as filled boxes, and noncoding first exons are shaded boxes. Noncoding sections of transcripts are shown as gray lines,
whereas coding sections are black. Arrows show initiation and direction of transcription. The arrow corresponding to the paternalGnas allele is shown as a dotted
line to indicate thatGnas is onlymaternally expressed in some tissues.MicroRNAs are represented as vertical lines.Maternally and paternallymethylated regions
are indicated by plus signs above and below the line, respectively. Figure not to scale (adapted with permission from reference 45).
TABLE 1 Summary of Gnas cluster mouse methods
Phenotype
Mutation Inheritance Protein(s) affected Neonate Adult References
Deletion of Gnas exon 1 Paternal Gs (paternal) Normal body wt, normal metabolic
rate, normal activity levels
12, 25
Maternal Gs (maternal) Perinatal lethality, edema Severe adiposity,2metabolic rate,
2 length, normal food intake
12, 25
Deletion of Gnas exon 2 Paternal Gs (paternal), XLs,
XLN1, ALEX?
Perinatal lethality, poor suckling,
2 adiposity, thin
2 Adiposity,1metabolic rate,2
length,1 SNS activity
68, 69
Maternal Gs (maternal) Perinatal lethality, edema,1
adiposity
1 Adiposity,2metabolic rate,2
length,2 SNS activity
68, 69
Deletion of Gnasxl exon Paternal XLs, XLN1, ALEX Perinatal lethality, poor suckling,
adiposity
2 Adiposity,1metabolic rate,2
length,1 SNS activity
48, 65
Duplication of distal
chromosome 2
(paternal)
NAa Gs (maternal),
Nesp55,1 XLs,
XLN1, ALEX?
Perinatal lethality, edema, wide
body, hyperactivity,1 length
(long bones)
10, 62
Duplication of distal
chromosome 2
(maternal)
NA XLs, XLN1, ALEX,
1 Nesp55, Gs
Perinatal lethality, no suckling,
narrow body, hypoactivity
10, 62
ENU point mutation of
Gnas exon 6
(Oed/Sml)
Paternal Gs (paternal), XLs Prenatal lethality,b suckling
unaffected, small body size
Adiposity unaffected by high-fat
diet,1metabolic rate, small
body size,2 wt,2 BMI
11, 32
a NA, not applicable.
b S. Ball, unpublished data.
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resources, whereas maternal genes in offspring are less de-
manding (41).
Imprinted expression of the protein coding genes within the
Gnas cluster is regulated by an imprinting control region (ICR), a
differentially methylated region (DMR) that is maternally meth-
ylated and includes the promoter of a noncoding paternally ex-
pressed transcript, Nespas, that is transcribed antisense to Nesp
(63, 64) (Fig. 1). A second maternally methylated DMR, the Exon
1ADMR, located just upstream of theGnas promoter, specifically
regulates the imprinted expression ofGnas (38, 61) (Fig. 1). Thus,
the ICRmust interact with the Exon 1ADMR, which in turnmust
act on Gnas to control its tissue-specific imprinting. The Exon 1A
DMR encompasses a 2.5-kb region that contains a promoter for a
noncoding RNA, Exon 1A, that is ubiquitous and exclusively pa-
ternally expressed, as well as the first exon of this transcript. This
noncoding RNA, like other transcripts in the cluster, arises from a
unique first exon that splices onto exon 2 of Gnas and extends
through to exon 12 ofGnas. It is unknown how the unmethylated
paternal Exon 1ADMR repressesGnas expression in some tissues.
One possibility is transcriptional repression from the Exon 1A
promoter; another is transcriptional interference from the Exon
1A transcript itself. In order to investigate further the regulation of
Gnas by Exon 1A, or the Exon 1A promoter, we have generated a
truncation of the Exon 1A transcript through insertion of a polyade-
nylation [poly(A)] cassette, designatedEx1A-T, as well as an inverted
truncation control in which the poly(A) cassette was inserted in the
opposite orientation, designatedEx1A-T-CON.Hereweprovide fur-
ther insight into how Exon 1A regulatesGnas.
Studies of the phenotypes seen on paternal inheritance of
Ex1A-T-CON and Ex1A-T have provided greater understanding
of the role of the Gnas cluster in metabolism and suckling. Pater-
nal inheritance of Ex1A-T-CON results in loss of imprinting of
Gnas and postnatal growth retardation, indicating that overex-
pression of Gnas gives rise to a deleterious phenotype. Paternal
inheritance of Ex1A-T gives rise to not only loss of imprinting of
Gnas but also loss of expression of XLs and XLN1. ALEX, how-
ever, is presumed to remain intact. Our results suggest that ALEX
may play a role in suckling behavior. Gnasxl has previously been
shown to play a role in fatmetabolism, but herewe show it also has
a role in bone metabolism as well. In the past few years, it has
become clear that adipocytemetabolism and bonemetabolism are
coregulated (18). For example, a number of key players in adipo-
genesis, such as leptin and peroxisome proliferator-activated re-
ceptor , have been shown to regulate bone remodeling while the
osteoblast-specific hormone osteocalcin has been shown to regu-
late fat mass (29).Gnasxlmay also be involved in the coregulation
of bone and adipocytes. Although inactivating mutations of Gnas
give rise to a number of bone phenotypes (6, 49, 51, 52, 59), this is
the first report, as far as we are aware, of a bone phenotype that is
specific to Gnasxl.
MATERIALS AND METHODS
Construction of the targeting vector. The targeting constructs were de-
signed to insert a poly(A) cassette derived from the rabbit -globin gene
(57) into the Exon 1A exon in both orientations at position 184080
(AL593857.10) (Fig. 2A). The constructs were generated by homologous
recombination in yeast (58). Briefly, a 1.2-kb fragment (nucleotides 31392
to 32553;M18818) from the rabbit -globin gene containing part of exon
2, complete intron 2, and exon 3 harboring the poly(A) signal was cloned
in both orientations into an XhoI site, 5= of the loxP site flanking the
selection cassette, in pRAY-Cre (AJ627603). The 5= and 3= recombino-
genic arms with homology to the Exon 1A exon, extending upstream and
downstream of the site of insertion of the polyadenylation cassette, were
amplified by PCR; the 5= arm was cloned 5= of the polyadenylation cas-
sette, and the 3= arm was cloned downstream of the 3= loxP site. A linear
fragment comprising the recombinogenic arms, poly(A) cassette, and se-
lection cassette was cotransformed into yeast YPH501with a 12-kbmouse
genomic EcoRI fragment, encompassing the Exon 1A exon andGnas exon
1, cloned in the yeast-Escherichia coli shuttle vector pRS414 (61) using a
yeast transformation kit (Sigma). The recombined shuttle vector was re-
covered from yeast colonies using the Zymoprep II kit (Cambridge Bio-
science) and electroporated into E. coli prior to targeting. All primer se-
quences are available on request. For both targeting constructs, the left
arm was 9.2 kb and the right arm was 2.7 kb.
Targeting of embryonic stem (ES) cells andmouse husbandry. Both
targeting constructs were linearized with NotI and electroporated into
MAC3 ES cells derived from mouse strain 129/Sv/Ev (50, 61). Colonies
surviving the G418 selection for both targeting constructs were screened
for correct targeting by Southern blot analysis of EcoRV-digested
genomic DNA probed with a 1.3-kb EcoRI fragment (nucleotides 18357
to 19683; AL593857.10) that was located 3= of the right arm of the target-
ing constructs. Correct targeting at the 5= end was confirmed by probing
EcoRV-digested genomic DNA with a 1-kb PCR product (nucleotides
32979 to 33982; AL593857.10). Chimeras were generated by injecting tar-
geted ES cells into C57BL/6J blastocysts, followed by transfer to pseudo-
pregnant foster mothers (CD1M) (61). Excision of the floxed selection
cassette, containingUra3-Cre, occurred in the germ line of male chimeras
by testis-specific expression of cre recombinase (8). Transmitting male
chimeras were crossed with 129/SVEM mice, and heterozygotes were
maintained on a 129/SVEM background. Proper excision of the cassette
was confirmed by PCR amplification across the remaining loxP site.
Both the Ex1A-T and Ex1A-T-CON alleles were deposited with the
Mouse Genome Informatics group of the Jackson Laboratory as
Gnastm2Jop and Gnastm3Jop, respectively.
Micewere housed under specific-pathogen-free conditions in individ-
ually ventilated cages at 21  2°C and a humidity of 55%  10% and
subjected to a 12-h light/12-h dark cycle, in accordance with UK Home
Office Welfare Guidelines. Mice had free access to water (25 ppm chlo-
ride) and food containing 11.5 kcal% fat, 23.93 kcal% protein, and 61.57
kcal% carbohydrate (SDS, RM3 diet).
Genotyping. Genomic DNA was extracted from mouse biopsy
specimens. Genotyping for both mutations was performed by du-
plex PCR using primers GGAAAGTGCAAAGGTGCAGAT,
TTGCTTCAGGTGGCTGGTACCA, CTGTCTCATCATTTTGGCAAAG,
and CTCAAGGGGCTTCATGATGT.
RNA analysis. Total RNA was isolated using either the RNeasy or the
RNeasy lipid kit (Qiagen). For Northern blot analysis of Gnas, Exon 1A,
Gnasxl, and Actb, 1 to 3 g of RNA was loaded onto an agarose gel,
transferred to a nylon membrane, and hybridized to specific probes as
described previously (61, 63).Gnas, Exon 1A, andGnasxl riboprobes were
each targeted to the unique first exon of each transcript (nucleotides
186498 to 186579, 183915 to 184090, and 155917 to 156264;
AL593857.10, respectively). Primers pairs for real-time reverse transcrip-
tion (RT)-PCR were designed as described previously (24). cDNA was
synthesized from 4 to 5 g of RNA primed by random hexamers with a
SuperScript III First Strand cDNA Synthesis kit (Invitrogen). Real time
RT-PCR was performed on an ABI Prism 7500 Fast system (Applied Bio-
systems) using Fast SYBR green PCR Master Mix (Applied Biosystems).
Each reaction was done in triplicate with approximately 10 ng of cDNA
per reaction. Samples were normalized to glyceraldehyde 3-phosphate
dehydrogenase gene (Gapdh) levels. Analysis of data was carried out with
ABI Prism 7500 system software (version 1.4). Primers are shown in Table
2; Gapdh primers were described previously (17).
Methylation analysis. Genomic DNA was isolated from neonatal
brain and BAT using the AllPrep DNA/RNA kit (Qiagen). Methylation of
the Exon 1A DMR was then assessed as described previously (61).
Imprinted XLs Is Involved in Bone and Fat Metabolism
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FIG 2 Insertion of a poly(A) cassette into the Exon 1A exon in both orientations. (A) Schematic overview of insertion in the targeted alleles. A 12-kb EcoRI
fragment containing the Exon 1A exon and Gnas exon 1 was cloned into yeast shuttle vector pRS414. A donor fragment containing a rabbit -globin poly(A)
cassette (in either the forward or the reverse orientation); the Neo, Ura-3, and Cre genes between two loxP sites; and 0.4-kb recombinant arms on each side
homologous with the 5= and 3= sequence of the insertion point in the Exon 1A exon, was also transformed into yeast. Both yeast constructs were then linearized
and electroporated into ES cells, where they were screened for homologous recombination by Southern blot analysis. ER, EcoRI; EV, EcoRV; X, XhoI. (B)
Eaton et al.
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Western blotting. Total cell lysates were extracted using radioimmu-
noprecipitation assay buffer (phosphate-buffered saline with 1%Nonidet
P-40, 0.5% sodium deoxycholate, and 0.1% SDS). A 50-g sample of cell
lysate was loaded into each lane of a 4 to 12% gradient Bis-Tris NuPAGE
gel (Invitrogen). Proteins were transferred to a polyvinylidene difluoride
membrane (GEHealthcare) and probed with specific primary antibodies,
followed by horseradish peroxidase-conjugated goat anti-rabbit second-
ary antibody (Sigma) and then detected using the ECL plusWestern blot-
ting detection kit (GEHealthcare). The anti-rabbitGs antibody (1:1,000;
Calbiochem) (7, 23) is directed against the C-terminal Gs epitope
RMHLRQYELL. The rat anti-rabbit XLs antibody (1:1,000; gift from
W. B. Huttner) is directed against a glutathione S-transferase-tagged XL
exon fragment. Anti-rabbit glyceraldehyde 3-phosphate dehydrogenase
(Sigma G9295) was used as a loading control.
Mouse weights. Individual mice of both sexes on a standard diet were
weighed at birth and then weekly for 12 weeks. For each litter, which
contained bothwild-type andmutantmice, at each time point the average
wild-type weight of each sex was calculated and then each individual
mouse’s weight within the litter was taken as a percentage of the average
wild-type weight of the corresponding sex.
Dual-energy X-ray absorptiometry (DEXA) analysis. At 12 weeks of
age, male mice were weighed and given a nonrecoverable general anes-
thetic before scanning with a Lunar PIXImus Mouse Densitometer
(Wipro; GE Healthcare). Fat mass, lean mass, bone mineral density, and
body length were all measured.
Metabolic caging. At 13 weeks of age, male mice were weighed and
then individually housed in metabolic cages for 24 h, during which time
they had free access to preweighed food and water. After the 24-h time
period, the amounts of food and water consumed were measured. After
metabolic housing, the mice were then returned to their home cage.
Metabolic rate measurements. At 12 weeks of age, male mice were
weighed and then individually housed in indirect calorimetry cages (Oxy-
max; Columbus Instruments) for 22 h. Cages allowed free access to food
and water. Oxygen consumption, carbon dioxide consumption, respira-
tory exchange ratio, and heat production were all analyzed.
Plasma leptin analysis. Plasma samples were collected from 12-week-
old male mice. Leptin was then quantified using the mouse and rat leptin
enzyme-linked immunosorbent assay kit (BioVendor) and analyzed
using the FLUOstar OPTIMA ABS absorbance microplate reader
(BMG LABTECH).
Suckling activity.On postnatal day 5, suckling activity was assessed as
described previously (32). Briefly, themother was removed from the litter
for 2 h and then returned. Each mouse in the litter was weighed before
separation, just before the mother was returned (starved weight), and 2 h
after the mother had been returned (fed weight). The difference in the
starved and fed weights was calculated in terms of 75% of the starved
weight (53) and was taken as a measure of suckling ability.
Statisticalmethods.All comparisons were between cohorts ofmutant
and wild-type age-matched siblings and were made using an unpaired
two-tailed Student t test.
RESULTS
Truncation of Exon 1A. A poly(A) cassette from the rabbit
-globin gene (15, 54, 57) was inserted within the Exon 1A exon at
position 184080 (AL593857.10), 21 bp 5= from the end of the Exon
1A exon (as described in reference 39) in both a 5=-to-3= orienta-
tion to truncate the Exon 1A transcript (Ex1A-T) and in a 3=-to-5=
orientation as a control (Ex1A-T-CON) by homologous recombi-
nation in ES cells (Fig. 2A and B).
After germ line transmission of the targeted alleles, one single
line of each of the targeted alleles was analyzed and expression of
Exon 1A was assessed following paternal transmission in both
transgenic lines. To test that the Exon 1A transcript had been suc-
cessfully truncated in the/Ex1A-T (the maternal allele precedes
the paternal allele in all of the genotypes described here) mice, we
designed primers for real-time RT-PCR at the 3= end of the Exon
1A exon, after the poly(A) cassette insertion site and at the 5= end
ofGnas exon 2, so that only transcript downstream of the poly(A)
cassette would be analyzed. We then assayed transcript levels in a
number of different neonatal tissues in both the /Ex1A-T and
/Ex1A-T-CONmutants, as well as their wild-type siblings (Fig.
2C). Exon 1A levels were also assayed using Northern blot analysis
with a probe specific for the Exon 1A exon (Fig. 2D). Real-time
RT-PCR showed that Exon 1A transcript levels were much re-
duced 3= of the poly(A) cassette in the /Ex1A-T mouse com-
pared with those in the wild-type mouse. Upon Northern blot
analysis, a single transcript shorter than full-length Exon 1A was
detected, consistent with a form of the Exon 1A transcript trun-
cated within the Exon 1A exon. Thus, we conclude that truncation
of the Exon 1A transcript in /Ex1A-T mice has occurred as de-
signed.
When the poly(A) cassette was inserted in the reverse orienta-
tion in the /Ex1A-T-CON line, the Exon 1A levels were also
much reduced (Fig. 2C) and undetected by Northern blot assay
(Fig. 2D). One explanation for this low level of expression is that
incorporation of a 1.2-kb poly(A) cassette destabilized the full-
length Exon 1A transcript, which is only 17.8 kb. Methylation of
the Exon 1A DMR was assessed by methylation-sensitive restric-
Screening for correct targeting by Southern blot assay. Genomic DNA from ES cells was digested with EcoRV and hybridized with 5= and 3= probes, respectively.
The wild-type allele gives rise to a 27.7-kb fragment, while the targeted allele will give rise to a 19.5-kb or a 12.9-kb fragment for the 5= and 3= probes, respectively.
(C)Real-timeRT-PCRanalysis of theExon 1A transcript uponpaternal transmission in newborn tissues. Primerswere designed from the end of theExon 1A exon
to the start of Gnas exon 2. Expression was normalized to Gapdh. Error bars indicate the standard errors of the means. (D) Northern blot assay of Exon 1A and
a -actin loading control in newborn tissues. Pituitaries were pooled in groups of two, with a total of 4 animals being analyzed; BAT is representative of 10 to 14
samples analyzed per genotype. (E) Southern blot analysis of methylation of the Exon 1A promoter. Genomic DNA was first cut with BamHI to generate the
181728-to-184851 fragment (AL593857.10); this corresponds to the wild-type band of 3,124 bp. The inserted poly(A) cassette at 184080 of 1,313 bp [1,163 bp of
poly(A) plus 150 bp of loxP] has a BamHI site at the start of the poly(A) cassette; thus, when the cassette is inserted in the forward orientation in the Ex1A-T
mutation, two bands of 2,352 bp and 2,084 bp are observed, which correspond to the targeted allele, and when it is inserted in the reverse orientation in the
Ex1A-T-CONmutation, a band of 3,515 bp is observed, which corresponds to the targeted allele, and the second band of 921 bp is too small to be seen on the blot.
TABLE 2 Primers used in real-time RT-PCR
Description Sequence
Gnas exon 1A forward AGCTAACCCAAGGAGCACCTAA
Gnas exon 2 reverse GTTAAACCCATTAACATGCAGGA
Gnas exon 1 forward AGAAGGACAAGCAGGTCTACCG
Gnas XL exon forward ATAAGAAACGCAGCAAGCTCATC
Gnas XL exon reverse CATGTAGTCCATCTTCTCCTCCT
Gnas N1 exon reverse GGACTGTAGCCATCATCTAGTGG
Leptin exon 2 forward TGCCTATCCAGAAAGTCCAGGAT
Leptin exon 3 reverse TCATTGGCTATCTGCAGCACAT
Ucp1 exon 3 forward ACCACAGAAAGCTTGTCAACAC
Ucp1 exon 4 reverse CCCCTTCATGAGGTCATATGTTA
Imprinted XLs Is Involved in Bone and Fat Metabolism
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tion enzyme Southern blot assays in /Ex1A-T and /Ex1A-T-
CON mice (Fig. 2E). This revealed that the Exon 1A DMR con-
taining the Exon 1A promoter remained unmethylated on the
paternal allele of both /Ex1A-T and /Ex1A-T-CON mice.
Thus, loss of the Exon 1A transcript in/Ex1A-T-CONmice was
not due to gain of methylation of the Exon 1A promoter. In addi-
tion, insertion of the poly(A) cassette did not alter themethylation
pattern at the Exon 1A DMR. In conclusion, both mutant lines
showed loss of the full-length Exon 1A transcript.
ImprintedGnas is upregulated.Wenext examined the expres-
sionofGnas transcripts by real-timeRT-PCRandNorthernblotting.
TheproteinproductGswas assayedbyWesternblotting.Gnas/Gs
was assayed in both/Ex1A-T and/Ex1A-T-CON individuals and
their wild-type littermates in neonatal BAT and pituitary tissue, in
whichGnas is predominantlymaternally expressed, aswell as in neo-
natal tissues such as those of the brain, lung, and liver, in whichGnas
is biallelically expressed (Fig. 3 A to C).
Similar to previous reports on mice with a paternal deletion of
Exon 1A (38, 61), upon loss or truncation of the Exon 1A tran-
script, we observed raised expression levels ofGnas in tissues such
as neonatal BAT and pituitary tissue, where Gnas is normally ma-
ternally expressed and paternally repressed, but detected no
change in transcript levels in brain, liver, and lung tissues, which
are tissues in whichGnas normally shows biallelic expression. We
attribute the raised levels of Gnas in BAT and pituitary tissue to
loss of imprinted expression and derepression of Gnas on the pa-
ternal allele.
Expression of Gnasxl transcripts. We also assayed the effect
on production ofGnasxl transcripts, as the poly(A) cassette lies in
the first intron of Gnasxl. Real-time RT-PCR primers were de-
signed at the 3= end of the Gnas XL exon and at the 5= end of
Gnas/Gnasxl exon 2 to assay both the full-lengthGnasxl transcript
and the neural transcript XLN1 but not forms truncated by the
poly(A) cassette. Upon paternal transmission of the Ex1A-Tmu-
tation, therewas a significant reduction ofGnasxl transcripts, con-
sistent with truncation of both the full-length and neural XLN1
Gnasxl transcripts due to insertion of the poly(A) cassette (Fig.
4A). We also designed real-time RT-PCR primers at the 5= and 3=
ends of the Gnas XL exon which showed no significant change in
expression of the Gnas XL exon amplicon (Fig. 4B). This con-
firmed that the Gnasxl transcript was indeed truncated between
theGnas XL (1st) exon andGnas/Gnasxl exon 2 rather than loss of
expression resulting from ablation of theGnasxl transcript. Lastly,
we designed primers at the 3= end of the Gnas XL exon and the 5=
end of the neural N1 exon and carried out real-time RT-PCR
analysis specifically for XlN1 in the neonatal brain, which further
confirmed the loss of the full-length neural transcript (data not
shown). Northern blot assays of embryonic day 15.5 (E15.5) em-
bryos probed for the Gnas XL exon also confirmed a loss of full-
length Gnasxl (Fig. 4C).
In contrast, in the /Ex1A-T-CON mutation, there was no
obvious difference in the level of Gnasxl, indicating that inser-
tion of the polyadenylation cassette had not affected Gnasxl
expression (Fig. 4A and C). We next investigated whether the
FIG 3 Upregulation of Gnas. (A) Real-time RT-PCR analysis of Gnas transcript in newborn tissues. Primers were designed from the end of Gnas exon 1 to the
start of Gnas exon 2. Expression was normalized to Gapdh. Error bars indicate the standard errors of the means; **, P 0.05; ***, P 0.01. (B) Northern blot
assay ofGnas and a -actin loading control in newborn tissues. Pituitaries were pooled in groups of two, with a total of five animals analyzed per genotype. BAT
is representative of 10 to 14 samples analyzed. (C)Western blot assay of Gs and a GAPDH loading control in newborn tissues. Nine to thirteen pituitaries were
pooled for each genotype, and other tissues are representative of at least two samples analyzed per genotype.
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two mutations affected XLs protein levels by Western blot-
ting. Truncation of the Gnasxl transcript in /Ex1A-T but
not /Ex1A-T-CON mice resulted in loss of full-length XLs
protein (Fig. 4D).
The poly(A) truncation site is located downstream of theGnas
XL exon, and although both theGnasxl and XlN1 transcripts were
truncated and nonfunctional in the/Ex1A-Tmutation, we sur-
mise that the alternative reading frame protein, ALEX, which con-
tains its protein coding region solely within the Gnas XL exon,
would be intact and functional.
FIG 4 Truncation ofGnasxl. (A) Real-time RT-PCR analysis ofGnasxl transcript in newborn tissues. Primers were designed at the end of theGnas XL exon and
at the start ofGnas exon 2. Expression was normalized toGapdh. Error bars indicate the standard errors of themeans; P 0.005. (B) Real-time RT-PCR analysis
ofGnasxl transcript in newborn tissues. Primers were designed at the start and end of theGnas XL exon. Expressionwas normalized toGapdh. Error bars indicate
the standard errors of the means. (C) Northern blot assay of Gnasxl and a -actin loading control in E15.5 whole embryos. Results shown are representative of
3 to 5 samples per genotype. (D)Western blot assay of XLs and a GAPDH loading control in E15.5 whole embryos. Samples shown are representative of at least
two samples analyzed per genotype. (E) Schematic diagram summarizing the outcomes of the poly(A) cassette insertion in the/Ex1A-T and/Ex1A-T-CON
mutations on Gnas cluster transcripts on the paternal allele.
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In light of these results, we are presented with two different
mousemodels (Fig. 4E). Paternal transmission of the Ex1A-Tmu-
tation results in tissue-specific upregulation of Gs and loss of
XLs (and XLN1) protein but ALEX is presumed to be at wild-
type levels. Paternal transmission of the Ex1A-T-CON mutation
also results in tissue-specific upregulation of Gs, but XLs and
presumably ALEX are equivalent to the wild type. Next we inves-
tigated the phenotype of these mice.
Both mutations show reductions in growth. Within 24 h of
birth, neonatal pups were recorded and genotyped. The/Ex1A-
T-CON mice were found at expected Mendelian frequencies at
birth (50.6%of 316 neonates). The/Ex1A-Tmice occurredwith
a frequency of 45.5% (of 444 neonates), which is not significantly
different from the expected 50% when analyzed by the chi-
squared test (P 0.05).
Mice that paternally inherited Ex1A-T and Ex1A-T-CON and
their wild-type siblings of both sexes were weighed at birth and then
weekly for 12weeks to assess growth. Theweights of themutantmice
are shown as a percentage of that of their same-sexwild-type siblings,
and only data from mice that survived to 12 weeks were considered
(Fig. 5A). Both the /Ex1A-T-CON and /Ex1A-T mice were
smaller at birth, the/Ex1A-T-CONmice had 95% (P 0.009) and
the/Ex1A-Tmice had 92% (P 1 104) of the weight of their
wild-type siblings. Eighty-five percent of /Ex1A-T and 93% of
/Ex1A-T-CON mice survived past weaning. Most losses (75%)
were the smallest members of their litters and died between 1 and 2
weeks of age, when their weight gain was at its lowest. Both the
/Ex1A-T and /Ex1A-T-CON mice were growth retarded. This
was most evident at 2 weeks of age.
The /Ex1A-T-CON mice had 83% (P  1  1013) of the
weight of their wild-type siblings at 2weeks, after which point they
started to recover to near wild-type weights by 7 weeks (96%; P
0.01 to 0.1; 7 to 12 weeks). Weights of/Ex1A-Tmice were con-
siderably more reduced at 56% (P 1 1011) of those of their
wild-type siblings at 2 weeks of age; they too then started to make
a recovery but only to 75% (P 1 1011 to 1 1013; 7 to 12
weeks) of the wild-type weight. This indicates that both Gs and
XLs affect growth both postnatally andprenatally. Thus, upregu-
lation of Gnas in /Ex1A-T-CON mice gives rise to a growth
retardation, which is almost fully reversible, but upregulation of
Gnas together with loss ofGnasxl/XlN1 in/Ex1A-Tmice results
in severe growth retardation, which is only partially reversible.
/Ex1A-T mice have shorter body lengths. A shorter body
length has previously been reported in the Gnasxl knockout
mouse (65). Body and femur lengthsweremeasured at 12weeks of
age in both/Ex1A-T and/Ex1A-T-CONmice (Fig. 5B and C).
Mice that paternally inherited Ex1A-T had significantly shorter
body lengths (P 1 104) and also had shorter femur lengths
than their wild-type littermates (P  0.006), but there was no
significant difference in either body or femur length in the mice
that paternally inherited Ex1A-T-CON compared to their wild-
type siblings. This confirms the role of Gnasxl in the regulation of
body length and reveals for the first time that femur length is also
regulated by Gnasxl.
/Ex1A-T mice have less fat mass. At 12 weeks of age both
/Ex1A-T and /Ex1A-T-CON mice were analyzed by DEXA.
The/Ex1A-Tmice had less total fat and less total leanmass than
their wild-type siblings (2.7 versus 4.9 g of fat mass [P  1 
106], 15.4 versus 20.8 g of lean mass [P 1 107]). Further-
more, compared to their body weight, the /Ex1A-T mice had a
significantly lower percentage of fat mass (P  0.009) and a cor-
respondingly higher percentage of lean mass (P  0.0005) (Fig.
6A). Thus, the /Ex1A-T mice are smaller because they have an
FIG 5 Growth retardation. (A) Growth curve of /Ex1A-T and /Ex1A-T-
CONmice and their wild-type littermates of both sexes over 12 weeks. Wild-
type littermate weights have been normalized to 1 at each time point, and
weights of the transgenic mice have been taken as a percentage of wild-type
weights at each time point. Error bars indicate the standard errors of the
means; n  14 to 34. (B) Body lengths of 12-week-old-mice, measured from
the nose to the start of the tail. Error bars indicate the standard errors of the
means; ***, P  0.01. (C) Femur lengths of 12-week-old-mice. Error bars
indicate the standard errors of the means; ***, P 0.01.
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absolute reduction of both lean and fat masses with a dispropor-
tionately greater reduction of fat mass. Similar effects on total fat
and lean mass, as well as percentages of fat and lean mass, were
seen in/Ex1A-T-CONmice compared with their wild-type sib-
lings, but these differences were not statistically significant. The
bodymass index (BMI) of the/Ex1A-Tmice, but not that of the
/Ex1A-T-CONmice, was also found to be significantly reduced
at 2 and 12 weeks (2.3 versus 2.8 [P 0.03, n 3 to 6] at 2 weeks;
2.2 versus 2.9 [P 1 106, n 6 to 11] at 12 weeks).
Reduction of fatmass is not due to diet.To ascertain the cause
of the observed lower fat mass, 12-week-old-mice were housed in
metabolic cages, where their food and water intake was measured
over a 24-h period. There was no difference in food intake in the
/Ex1A-T-CONmice. However, intriguingly the/Ex1A-Tmice
in fact ate significantlymore food than theirwild-type siblings (4.1
versus 3.6 g; P  0.04), an increase that was even more pro-
nounced when measured as a proportion of body weight (P 
0.0007) (Fig. 6B). We conclude that the reduction of fat mass of
the adult/Ex1A-Tmice was not in any way due to reduced food
intake.
No reduction in suckling in/Ex1A-Tpups.Previous studies
have shown that neonatalmice that lack allGnasxl transcripts have
reduced suckling ability (10, 48, 69). Thus, we measured suckling
ability in 5-day-old /Ex1A-T and /Ex1A-T-CON mice and
their wild-type littermates after a 2-h separation from themother.
Suckling ability was assessed in 5-day-old mice by the difference
between starved and fed body weights measured in terms of body
weight to account for the smaller weight of the mutant mice. We
observed no difference in the suckling abilities of 20 /Ex1A-T-
CONmice and 16 wild-type littermates (3.66% versus 4.31%, P
0.41), indicating that overexpression of Gs has no effect on suck-
ling ability. There was also no significant difference in the suckling
ability of the 26/Ex1A-Tmice and that of 21 wild-type controls
(3.34% versus 4.23%, P  0.28). This is comparable to results
found in the Sml mice, which have nonfunctional XLs but in
which XLN1 and ALEX are presumed to be functional (32).
/Ex1A-Tmice have a higher metabolic rate. Twelve-week-
old /Ex1A-T but not /Ex1A-T-CON mice showed significant
increases in both oxygen consumption and carbon dioxide output
(Fig. 6C). This is indicative of an increased metabolic rate in the
/Ex1A-Tmice, which is consistent with a reduction of fat mass.
/Ex1A-T mice have a lower bone mineral density. Bone
mineral density was also assessed during analysis of 12-week-old
/Ex1A-T and /Ex1A-T-CON mice by DEXA (Fig. 7A).
/Ex1A-T mice were found to have a significant reduction in
bone mineral density. In contrast,/Ex1A-T-CONmice showed
no difference in bone mineral density.
Leptin is downregulated. Serum leptin levels were measured
in 12-week-old /Ex1A-T and /Ex1A-T-CON mice and their
wild-type siblings (Fig. 7B). Leptin mRNA levels were also mea-
sured in white adipose tissue (WAT) and BAT by real-time RT-
PCR in/Ex1A-Tmice and their wild-type littermates (Fig. 7C).
Leptin levels in serum and mRNA levels in WAT and BAT were
found to be significantly reduced in/Ex1A-Tmice. This is con-
sistent with their lean phenotype, as leptin circulates at levels pro-
portional to adiposity (40), and indeed, when leptin levels are
calculated relative to fat mass, there is no difference between the
/Ex1A-Tmice and their wild-type littermates. Low leptin levels
could also explain why the/Ex1A-Tmice are hyperphagic as low
leptin results in increased hyperphagia (21). There was no signif-
icant difference between the serum leptin levels of /Ex1A-T-
CONmice and those of their wild-type littermates.
Ucp1 is upregulated. Ucp1 is positively regulated by sympa-
thetic, -adrenergic, activity. Ucp1 levels were found to be up-
regulated in adult BAT of /Ex1A-T mice (Fig. 7D), and this is
indicative of an increase in sympathetic nervous system (SNS)
activity. Therewas no significant difference betweenUcp1 levels in
/Ex1A-T adult WAT and the wild type.
FIG 6 Analysis of adiposity. (A) Percentages of fat and lean masses of 12-
week-old male mice from DEXA analysis. Error bars indicate the standard
errors of the means; ***, P 0.01. (B) Percentages of food intake by 12-week-
old male mice. Error bars indicate the standard errors of the means; **, P 
0.05; ***, P  0.01. (C) Rates of oxygen consumption and carbon dioxide
output of 12-week-oldmalemice. Error bars indicate the standard errors of the
means; ***, P 0.01.
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DISCUSSION
We initially set out to further elucidate the mechanisms whereby
Exon 1A brings about silencing of Gnas on the paternal allele.
Proposedmechanisms include competition between theGnas and
Exon 1A promoters for shared transcription elements, binding of
tissue-specific methylation-sensitive silencing or activating fac-
tors to the Exon 1A DMR, or transcriptional interference of the
Exon 1A transcript across theGnas promoter or the Exon 1A tran-
script itself (45).
In both/Ex1A-T and/Ex1A-T-CON mice, loss or trunca-
tion of the Exon 1A transcript resulted in loss of imprinted expres-
sion of Gnas. Promoter competition is unlikely to account for
these findings, as the Exon 1A promoter sequence was not dis-
rupted in either the Ex1A-T or the Ex1A-T-CON allele.Moreover,
as shown in the Northern blot assays of Exon 1A (Fig. 2D), trun-
cated Exon 1A transcript was transcribed in /Ex1A-T mice, in-
dicating a functional Exon 1A promoter.
Our findings are consistent with a transcriptional interference
model whereby transcription of Exon 1A across the Gnas pro-
moter can bring about silencing ofGnas. Evidence supporting the
transcriptional interference model includes the finding that Exon
1A levels are highest in tissues in which Gnas is paternally re-
pressed, i.e., neonatal BAT and pituitary tissue (Fig. 2C) and also
that Exon 1A-mediated repression of Gnas occurs in cis (63).
However, neither the silencer nor the enhancer model can be
ruled out, as both mutations involve insertion of exogenous DNA
into the Gnas locus. Although the methylation status of the Exon
1A DMR remains unchanged in both mutants (Fig. 2E) and no
binding sites have been removed, the Exon 1A DMR covers the
region from position 3400 to position 939 upstream of the
Gnas exon 1 transcriptional start site and includes the Exon 1A
exon itself, as well as approximately 1 kb upstream and 1.5 kb
downstream of the Exon 1A exon (39). Thus, insertion of a 1.2-kb
cassette within this DMR may well have disrupted binding to si-
lencer or enhancer blocker elements.
Here we have shown that the /Ex1A-T-CON mice present
with postnatal growth retardation, but no change in bonemineral
density ormetabolic rate at 12 weeks of age when they have recov-
ered to 96% of the wild-type weight. This can be attributed solely
to loss of imprinting of Gnas, as Gnasxl expression, as well as all
other Gnas cluster protein-coding transcripts, is normal. In con-
trast, the /Ex1A-T mice show loss of imprinting of Gnas com-
bined with loss ofGnasxl. This gives rise to severe growth retarda-
tion, which is not fully reversible. The /Ex1A-T adult mice are
also shorter, have a lower bone mineral density, a reduced fat
mass, and an increasedmetabolic rate compared to their wild-type
siblings. Leptin was found to be downregulated in /Ex1A-T
mice, while Ucp1 was upregulated.
The parental conflict hypothesis for the evolution of imprint-
ing predicts that maternally expressed imprinted genes will be
growth inhibiting whereas paternally expressed imprinted genes
will be growth promoting (41). Thus, the finding that upregula-
tion of a maternally expressed gene, Gnas, gives rise to mice that
are smaller than their wild-type siblings, as seen in the /Ex1A-
FIG 7 (A) Bone mineral densities of 12-week-old male mice from DEXA analysis. Error bars indicate the standard errors of the means; **, P 0.05. (B) Serum
leptin levels of 12-week-old male mice. Error bars indicate the standard errors of the means; **, P 0.05. (C) Leptin levels in 12-week-old male BAT andWAT
by real-time RT-PCR. Error bars indicate the standard errors of the means; **, P 0.05, ***, P 0.01. (D) Ucp1 levels in 12-week-old male BAT by real-time
RT-PCR. Error bars indicate the standard errors of the means; ***, P 0.01.
Eaton et al.
1026 mcb.asm.org Molecular and Cellular Biology
 o
n
 June 19, 2014 by guest
http://m
cb.asm
.org/
D
ow
nloaded from
 
T-CONmice, is consistent with the hypothesis, and so is the find-
ing that when both maternally expressed Gnas is upregulated and
paternally expressed Gnasxl is ablated, as is the case in/Ex1A-T
mice, there is an additive effect and these mice are even smaller
than those which only have an upregulation of Gnas.
Much of the phenotype observed in /Ex1A-T mice corre-
sponds to that seen in other mouse models that have a loss of
functional XLs such as Gnasxl knockout mice, MatDp(dist2)
mice, and Sml mice (10, 11, 32, 48, 62, 65, 68, 69). However,
whereas there are considerable prenatal losses of Sml (S. Ball, un-
published data) and MatDp(dist2) mice and Gnasxl knockout
mice show profound perinatal lethality,/Ex1A-Tmice have rel-
atively few preweaning losses and are essentially fully viable and
thus provide a goodmodel for investigation of the effects of loss of
Gnasxl. In addition to the above, we have reported here two other
novel findings upon loss of Gnasxl transcripts.
Unlike all other models with deficient Gnasxl expression, ex-
cept Sml mice, /Ex1A-T mice do not show suckling defects.
Suckling defects are characteristic of mice with paternally derived
deletions of either the Gnas XL exon (48) or Gnas exon 2 (69) or
mice withmaternal duplication/paternal deficiency of distal chro-
mosome 2,MatDp(dist2) (10). There are three well-characterized
paternal transcripts that encompass and originate at the Gnas XL
exon (Fig. 1). The first of these isGnasxl, a transcript which splices
from the Gnas XL exon into exon 2 of Gnas and is transcribed
through to exon 12 to generate the XLs protein. The second is
XLN1, which is very similar to Gnasxl, except that it contains an
alternate exon, N1, located after Gnas exon 3 and results in a
shortened, neurally specific transcript and encodes the XLN1 pro-
tein. The third transcript is ALEX, which is identical in nucleotide
sequence to Gnasxl, but the protein ALEX is generated from an
alternate reading frame within the Gnas XL exon and is only pro-
tein coding within this exon.
The protein products XLs, XLN1, and ALEX are all predicted
to be absent in MatDp(dist2) mice and mice with paternal dele-
tions of either the Gnas XL exon or Gnas exon 2. The Gnasxl
promoter is silent in MatDp(dist2), and an exon essential for all
three proteins is missing in Gnas XL exon deletion mice. Loss of
paternal Gnas exon 2 would certainly result in loss of XLs and
XLN1, as transcripts for both of these proteins are in part encoded
by this exon. Gnas exon 2 is also part of the 3= UTR of the ALEX
transcript, and its deletion is likely to destabilize theGnasxl/ALEX
transcript and result in loss of ALEX protein. Sml mice have a
pointmutation inGnas exon 6 (56) and thus have disruptedXLs,
but XLN1 and ALEX are thought to be unaffected. Here we have
shown that the/Ex1A-Tmice, which have a poly(A) truncation
site inserted between the Gnas XL exon and Gnas exon 2, lack
XLs and XLN1 but the ALEX protein is probably intact. Thus, in
Gnasxl mutants with suckling failure, ALEX is absent but in
Gnasxl mutants that suckle normally, ALEX is theoretically pres-
ent. Thus, we have shown that the suckling defects observed in
previously described Gnasxl mutants cannot be due to loss of
XLs or XLN1 and propose that this is due to loss of ALEX. Inter-
estingly,Gnasxl is expressed in brain nuclei that can affect suckling
(48) and as ALEX’s RNA is indistinguishable from Gnasxl RNA,
ALEX may be expressed in these regions as well. It also remains a
possibility that the suckling defects are due to poorly characterized
XXLb1, XXLb2, or some as-yet-undescribed transcript (1, 27).
The other phenotypes observed in /Ex1A-T mice (and not
/Ex1A-T-CON mice), namely; reduced body weight, reduced
adiposity, reduced body length, increased food consumption, in-
creased metabolic rate, increased Ucp1, and reduced leptin, have
also been found in other adult mouse models lacking Gnasxl (32,
65, 68). Thus, these phenotypes can be attributed to loss of XLs/
XLN1. While we did not analyze locomotor activity, previous
work has shown that loss of XLs has no effect on locomotor
activity in adult mice (65).
The second novel finding is the presence of a bone phenotype,
namely, that loss ofGnasxl results in a lowered bone mineral den-
sity. To our knowledge no previous study has identified a bone
density phenotype specifically associated with Gnasxl, although
bone phenotypes such as shortened bones and growth plate de-
fects have been observed inmice whenGnas expression is reduced
or ablated (6, 9, 51, 52). We propose here that XLs may provide
a new link between bone and adipocyte metabolism.
Understanding of the relationship between bone and adi-
pocyte metabolism has increased over recent years. Although the
exact mechanism of how bone and adipocytes are coregulated
remains controversial (37, 66), a substantial amount of thismech-
anism is known. Leptin has been shown to inhibit bone mass
through hypothalamic regulation of the SNS (19, 20). Leptin
binds to leptin receptors in the arcuate nucleus to release melano-
cortin peptides, which then bind to melanocortin receptors,
which signal downstream to regulate SNS activity (42). Bothmela-
nocortin 3 and 4 receptors (MC3R/MC4R) are Gs-coupled recep-
tors which are expressed in the hypothalamus and are involved in
regulating energy homeostasis (42). The SNS regulates bone me-
tabolism through -adrenergic pathways (20, 22) and also inner-
vates WAT to positively regulate lipolysis in this organ (3, 4, 55,
67). In a wild-type mouse, leptin is expressed from adipocytes at a
rate proportional to fat mass. High levels of circulating leptin act
at the hypothalamus through the melanocortin pathway to in-
crease -adrenergic SNS activity to reduce bone and adipocyte
mass, which in turn reduces the amount of circulating leptin (Fig.
8). How the melanocortin pathway regulates SNS activity down-
stream of the melanocortin receptors is as yet unknown.
In adults,Gnasxl is expressed primarily in neuroendocrine tis-
sues such as the orexigenic neurons of the hypothalamus (28, 31,
43, 44). It is not expressed in adultWATandBAT (65) andwas not
detectable in adult bone by real-time RT-PCR in the present study
(data not shown).
We hypothesize that XLs acts in the hypothalamus down-
stream of the MC3R/MC4R to repress SNS activity and thus re-
press bone formation and adipogenesis. In the absence of XLs,
leptin is unable tomediate its effects throughMC3R/MC4R at the
hypothalamus to repress SNS activity due to loss of XLs. Conse-
quently, SNS activity is upregulated, resulting in a decrease in
bone andWATmass. Thus, we propose that the bone and adipose
phenotype observed due to loss of XLs can be explained by XLs
acting downstream of leptin in the hypothalamus to mediate SNS
activity. There is evidence that regulation of the SNS by XLs
occurs from birth, as newborn pups that lack XLs have been
shown to have increased cAMP levels in BAT (48) which is con-
sistent with an upregulation of SNS activity. Thus, XLs may reg-
ulate bone formation through the SNS throughout life.
The decrease inWAT is expected to lead to a decrease in leptin,
resulting in an increased appetite. Regulation of appetite by leptin
through the melanocortin pathway does not occur through the
SNS; instead, this appears to be regulated through Sim1 down-
stream of MC4R in the paraventricular nucleus of the hypothala-
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mus (2, 36). In animals without XLs, low levels of leptin would
act to increase appetite and thus food intake in an XLs-
independent (possibly Sim1) pathway.
ACKNOWLEDGMENTS
This work was supported by the UK Medical Research Council and the
Wellcome Trust.
We thank Denise Barlow and Frank Sleutels for providing a cloned
fragment of the rabbit -globin gene. We also thank Bruce Cattanach for
comments on the manuscript; Chris Esapa and Rosario Romero for tech-
nical advice; staff of the Mary Lyon Centre (MLC) for animal husbandry,
in particular, Lynn Jones, Diane Napper, Jackie Harrison, Kelly Hunt,
Lucie Vizor, and Sara Wells; the MLC transgenic service; and the MLC
necropsy service.
REFERENCES
1. Abramowitz J, Grenet D, Birnbaumer M, Torres HN, Birnbaumer L.
2004. XLalphas, the extra-long form of the alpha-subunit of the Gs G
protein, is significantly longer than suspected, and so is its companion
Alex. Proc. Natl. Acad. Sci. U. S. A. 101:8366–8371.
2. Balthasar N, et al. 2005. Divergence of melanocortin pathways in the
control of food intake and energy expenditure. Cell 123:493–505.
3. Bamshad M, Aoki VT, Adkison MG, Warren WS, Bartness TJ. 1998.
Central nervous systemorigins of the sympathetic nervous systemoutflow
to white adipose tissue. Am. J. Physiol. 275:R291–R299.
4. Bartness TJ, Song CK. 2007. Thematic review series: adipocyte biology.
Sympathetic and sensory innervation of white adipose tissue. J. Lipid Res.
48:1655–1672.
5. Bastepe M, et al. 2002. Receptor-mediated adenylyl cyclase activation
through XLalpha(s), the extra-large variant of the stimulatory G protein
alpha-subunit. Mol. Endocrinol. 16:1912–1919.
6. Bastepe M, et al. 2004. Stimulatory G protein directly regulates hyper-
trophic differentiation of growth plate cartilage in vivo. Proc. Natl. Acad.
Sci. U. S. A. 101:14794–14799.
7. Baxendale RW, Fraser LR. 2003. Immunolocalization of multiple Galpha
subunits in mammalian spermatozoa and additional evidence for Gal-
phas. Mol. Reprod. Dev. 65:104–113.
8. Bunting M, Bernstein KE, Greer JM, Capecchi MR, Thomas KR. 1999.
Targeting genes for self-excision in the germ line. Genes Dev. 13:1524–
1528.
9. Castrop H, et al. 2007. Skeletal abnormalities and extra-skeletal ossifica-
tion in mice with restricted Gsalpha deletion caused by a renin promoter-
Cre transgene. Cell Tissue Res. 330:487–501.
10. Cattanach BM, Kirk M. 1985. Differential activity of maternally and
paternally derived chromosome regions in mice. Nature 315:496–498.
11. Cattanach BM, Peters J, Ball S, Rasberry C. 2000. Two imprinted gene
mutations: three phenotypes. Hum. Mol. Genet. 9:2263–2273.
12. ChenM, et al. 2005. Alternative Gnas gene products have opposite effects
on glucose and lipidmetabolism. Proc. Natl. Acad. Sci. U. S. A. 102:7386–
7391.
13. Chen M, Nemechek NM, Mema E, Wang J, Weinstein LS. 2011. Effects
of deficiency of theGproteinGson energy and glucose homeostasis. Eur.
J. Pharmacol. 660:119–124.
14. Chen M, et al. 2009. Central nervous system imprinting of the G protein
G(s)alpha and its role in metabolic regulation. Cell Metab. 9:548–555.
15. Chotalia M, et al. 2009. Transcription is required for establishment of
germline methylation marks at imprinted genes. Genes Dev. 23:105–117.
16. Crawford JA, et al. 1993. Neural expression of a novel alternatively spliced
and polyadenylated Gs alpha transcript. J. Biol. Chem. 268:9879–9885.
17. de Bovis B, et al. 2005. clc is co-expressed with clf or cntfr in developing
mouse muscles. Cell Commun. Signal 3:1.
18. de Paula FJ, Horowitz MC, Rosen CJ. 2010. Novel insights into the
relationship between diabetes and osteoporosis. DiabetesMetab. Res. Rev.
26:622–630.
19. Ducy P, et al. 2000. Leptin inhibits bone formation through a hypotha-
lamic relay: a central control of bone mass. Cell 100:197–207.
20. Elefteriou F, et al. 2005. Leptin regulation of bone resorption by the
sympathetic nervous system and CART. Nature 434:514–520.
21. Friedman JM, Halaas JL. 1998. Leptin and the regulation of body weight
in mammals. Nature 395:763–770.
22. Fu L, Patel MS, Bradley A, Wagner EF, Karsenty G. 2005. The molecular
clock mediates leptin-regulated bone formation. Cell 122:803–815.
23. Fukao M, Mason HS, Kenyon JL, Horowitz B, Keef KD. 2001. Regula-
tion of BK(Ca) channels expressed in human embryonic kidney 293 cells
by epoxyeicosatrienoic acid. Mol. Pharmacol. 59:16–23.
24. Funnell AP, et al. 2007. Erythroid Kruppel-like factor directly activates
the basic Kruppel-like factor gene in erythroid cells. Mol. Cell. Biol. 27:
2777–2790.
25. Germain-Lee EL, et al. 2005. A mouse model of Albright hereditary
osteodystrophy generated by targeted disruption of exon 1 of the Gnas
gene. Endocrinology 146:4697–4709.
26. Hayward BE, et al. 2001. Imprinting of the G(s)alpha gene GNAS1 in the
pathogenesis of acromegaly. J. Clin. Invest. 107:R31–R36.
27. Holmes R, Williamson C, Peters J, Denny P, Wells C. 2003. A compre-
hensive transcript map of the mouse Gnas imprinted complex. Genome
Res. 13:1410–1415.
28. Ivanova E, Kelsey G. 2011. Imprinted genes and hypothalamic function.
J. Mol. Endocrinol. 47:R67–R74.
29. Kawai M, Devlin MJ, Rosen CJ. 2009. Fat targets for skeletal health. Nat.
Rev. Rheumatol. 5:365–372.
30. Kaya AI, Ugur O, Oner SS, Bastepe M, Onaran HO. 2009. Coupling of
beta2-adrenoceptors to XLalphas and Galphas: a new insight into ligand-
induced G protein activation. J. Pharmacol. Exp. Ther. 329:350–359.
31. Kehlenbach RH, Matthey J, Huttner WB. 1994. XL alpha s is a new type
of G protein. Nature 372:804–809.
32. Kelly ML, et al. 2009. A missense mutation in the non-neural G-protein
alpha-subunit isoforms modulates susceptibility to obesity. Int. J. Obes.
(Lond.) 33:507–518.
33. Kelsey G, et al. 1999. Identification of imprinted loci by methylation-
sensitive representational difference analysis: application to mouse distal
chromosome 2. Genomics 62:129–138.
34. Klemke M, Kehlenbach RH, Huttner WB. 2001. Two overlapping read-
ing frames in a single exon encode interacting proteins—a novel way of
gene usage. EMBO J. 20:3849–3860.
35. Klemke M, et al. 2000. Characterization of the extra-large G protein
alpha-subunit XLalphas. II. Signal transduction properties. J. Biol. Chem.
275:33633–33640.
36. Kublaoui BM, Holder JL, Jr, Gemelli T, Zinn AR. 2006. Sim1 haploin-
FIG 8 Model of how leptin regulates the SNS and thus bone and adipocyte
formation through the hypothalamus. We hypothesize that XLs may be in-
volved in this regulatory loop by coupling tomelanocortin receptors 3 and 4 in
the hypothalamus.
Eaton et al.
1028 mcb.asm.org Molecular and Cellular Biology
 o
n
 June 19, 2014 by guest
http://m
cb.asm
.org/
D
ow
nloaded from
 
sufficiency impairs melanocortin-mediated anorexia and activation of
paraventricular nucleus neurons. Mol. Endocrinol. 20:2483–2492.
37. Lam DD, et al. 2011. Leptin does not directly affect CNS serotonin
neurons to influence appetite. Cell Metab. 13:584–591.
38. Liu J, et al. 2005. Identification of the control region for tissue-specific
imprinting of the stimulatory G protein alpha-subunit. Proc. Natl. Acad.
Sci. U. S. A. 102:5513–5518.
39. Liu J, Yu S, Litman D, Chen W, Weinstein LS. 2000. Identification of a
methylation imprint mark within the mouse Gnas locus. Mol. Cell. Biol.
20:5808–5817.
40. Maffei M, et al. 1995. Leptin levels in human and rodent: measurement of
plasma leptin and ob RNA in obese and weight-reduced subjects. Nat.
Med. 1:1155–1161.
41. Moore T, Haig D. 1991. Genomic imprinting in mammalian develop-
ment: a parental tug-of-war. Trends Genet. 7:45–49.
42. Oswal A, Yeo GS. 2007. The leptin melanocortin pathway and the control
of body weight: lessons from human and murine genetics. Obes. Rev.
8:293–306.
43. Pasolli HA, Huttner WB. 2001. Expression of the extra-large G protein
alpha-subunit XLalphas in neuroepithelial cells and young neurons dur-
ing development of the rat nervous system. Neurosci. Lett. 301:119–122.
44. Pasolli HA, Klemke M, Kehlenbach RH, Wang Y, Huttner WB. 2000.
Characterization of the extra-large G protein alpha-subunit XLalphas. I.
Tissue distribution and subcellular localization. J. Biol. Chem. 275:33622–
33632.
45. Peters J, et al. 2006. Imprinting control within the compact Gnas locus.
Cytogenet. Genome Res. 113:194–201.
46. Peters J,Williamson CM. 2007. Control of imprinting at the Gnas cluster.
Epigenetics 2:207–213.
47. Peters J, et al. 1999. A cluster of oppositely imprinted transcripts at the
Gnas locus in the distal imprinting region of mouse chromosome 2. Proc.
Natl. Acad. Sci. U. S. A. 96:3830–3835.
48. Plagge A, et al. 2004. The imprinted signaling protein XL alpha s is
required for postnatal adaptation to feeding. Nat. Genet. 36:818–826.
49. Plagge A, Kelsey G, Germain-Lee EL. 2008. Physiological functions of the
imprintedGnas locus and its protein variantsGalpha(s) andXLalpha(s) in
human and mouse. J. Endocrinol. 196:193–214.
50. Ramírez-Solis R, Davis AC, Bradley A. 1993. Gene targeting in embry-
onic stem cells. Methods Enzymol. 225:855–878.
51. Sakamoto A, Chen M, Kobayashi T, Kronenberg HM, Weinstein LS.
2005. Chondrocyte-specific knockout of the G protein G(s)alpha leads to
epiphyseal and growth plate abnormalities and ectopic chondrocyte for-
mation. J. Bone Miner Res. 20:663–671.
52. Sakamoto A, et al. 2005. Deficiency of the G-protein alpha-subunit
G(s)alpha in osteoblasts leads to differential effects on trabecular and cor-
tical bone. J. Biol. Chem. 280:21369–21375.
53. Schmidt-Nielsen K. 1990. Energy metabolism, metabolic rate and body
size, p 192–201. In Animal physiology, 4th ed. Cambridge University
Press, Cambridge, United Kingdom.
54. Shin JY, Fitzpatrick GV, Higgins MJ. 2008. Two distinct mechanisms of
silencing by the KvDMR1 imprinting control region. EMBO J. 27:168–
178.
55. Shrestha YB, et al. 2010. Central melanocortin stimulation increases
phosphorylated perilipin A and hormone-sensitive lipase in adipose tis-
sues. Am. J. Physiol. Regul. Integr. Comp. Physiol. 299:R140–R149.
56. Skinner JA, Cattanach BM, Peters J. 2002. The imprinted oedematous-
smallmutation onmouse chromosome 2 identifies new roles forGnas and
Gnasxl in development. Genomics 80:373–375.
57. Sleutels F, Zwart R, Barlow DP. 2002. The non-coding Air RNA is
required for silencing autosomal imprinted genes. Nature 415:810–813.
58. Storck T, Kruth U, Kolhekar R, Sprengel R, Seeburg PH. 1996. Rapid
construction in yeast of complex targeting vectors for gene manipulation
in the mouse. Nucleic Acids Res. 24:4594–4596.
59. Weinstein LS. 2006. G(s) alpha mutations in fibrous dysplasia and
McCune-Albright syndrome. J. BoneMiner Res. 21(Suppl 2):P120–P124.
60. Weinstein LS, Xie T, Qasem A, Wang J, Chen M. 2010. The role of
GNAS and other imprinted genes in the development of obesity. Int. J.
Obes. (Lond.) 34:6–17.
61. Williamson CM, et al. 2004. A cis-acting control region is required ex-
clusively for the tissue-specific imprinting of Gnas. Nat. Genet. 36:894–
899.
62. Williamson CM, et al. 1998. Imprinting of distal mouse chromosome 2 is
associated with phenotypic anomalies in utero. Genet. Res. 72:255–265.
63. Williamson CM, et al. 2006. Identification of an imprinting control
region affecting the expression of all transcripts in the Gnas cluster. Nat.
Genet. 38:350–355.
64. Wroe SF, et al. 2000. An imprinted transcript, antisense to Nesp, adds
complexity to the cluster of imprinted genes at the mouse Gnas locus.
Proc. Natl. Acad. Sci. U. S. A. 97:3342–3346.
65. Xie T, et al. 2006. The alternative stimulatory G protein alpha-subunit
XLalphas is a critical regulator of energy and glucose metabolism and
sympathetic nerve activity in adult mice. J. Biol. Chem. 281:18989–18999.
66. Yadav VK, et al. 2009. A serotonin-dependent mechanism explains the
leptin regulation of bone mass, appetite, and energy expenditure. Cell
138:976–989.
67. Youngstrom TG, Bartness TJ. 1995. Catecholaminergic innervation of
white adipose tissue in Siberian hamsters. Am. J. Physiol. 268:R744–R751.
68. Yu S, et al. 2000. Paternal versus maternal transmission of a stimulatory
G-protein alpha subunit knockout produces opposite effects on energy
metabolism. J. Clin. Invest. 105:615–623.
69. Yu S, et al. 1998. Variable and tissue-specific hormone resistance in
heterotrimeric Gs protein alpha-subunit (Gsalpha) knockout mice is due
to tissue-specific imprinting of the gsalpha gene. Proc. Natl. Acad. Sci.
U. S. A. 95:8715–8720.
Imprinted XLs Is Involved in Bone and Fat Metabolism
March 2012 Volume 32 Number 5 mcb.asm.org 1029
 o
n
 June 19, 2014 by guest
http://m
cb.asm
.org/
D
ow
nloaded from
 
